153 related articles for article (PubMed ID: 19733956)
1. Prediction of pelvic pathology in subfertile women with combined Chlamydia antibody and CA-125 tests.
Penninx J; Brandes M; de Bruin JP; Schneeberger PM; Hamilton CJ
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):178-82. PubMed ID: 19733956
[TBL] [Abstract][Full Text] [Related]
2. Chlamydial antibody, as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility.
Minassian SS; Wu CH; Jungkind D; Gocial B; Filer RB; Glassner M
J Reprod Med; 1990 Feb; 35(2):141-5. PubMed ID: 2137537
[TBL] [Abstract][Full Text] [Related]
3. Chlamydial serology and histerosalpingography in predicting tubal disease in infertility patients.
Fiçicioğlu C; Api M
Acta Eur Fertil; 1995; 26(3):109-12. PubMed ID: 9098470
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopy.
Ng EH; Tang OS; Ho PC
Hum Reprod; 2001 Apr; 16(4):775-9. PubMed ID: 11278232
[TBL] [Abstract][Full Text] [Related]
5. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings.
Eschenbach DA; Wölner-Hanssen P; Hawes SE; Pavletic A; Paavonen J; Holmes KK
Obstet Gynecol; 1997 Feb; 89(2):184-92. PubMed ID: 9015018
[TBL] [Abstract][Full Text] [Related]
6. The role of chlamydia genus-specific and species-specific IgG antibody testing in predicting tubal disease in subfertile women.
den Hartog JE; Land JA; Stassen FR; Slobbe-van Drunen ME; Kessels AG; Bruggeman CA
Hum Reprod; 2004 Jun; 19(6):1380-4. PubMed ID: 15105400
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of medical history taking and Chlamydia IgG ELISA antibody testing (CAT) in the selection of subfertile women for diagnostic laparoscopy: a clinical prediction model approach.
Coppus SF; Opmeer BC; Logan S; van der Veen F; Bhattacharya S; Mol BW
Hum Reprod; 2007 May; 22(5):1353-8. PubMed ID: 17234674
[TBL] [Abstract][Full Text] [Related]
8. Integration of patient characteristics and the results of Chlamydia antibody testing and hysterosalpingography in the diagnosis of tubal pathology: an individual patient data meta-analysis.
Broeze KA; Opmeer BC; Coppus SF; Van Geloven N; Den Hartog JE; Land JA; Van der Linden PJ; Ng EH; Van der Steeg JW; Steures P; Van der Veen F; Mol BW
Hum Reprod; 2012 Oct; 27(10):2979-90. PubMed ID: 22851718
[TBL] [Abstract][Full Text] [Related]
9. Pelvic factor infertility: diagnosis and prognosis of various procedures.
Bulletti C; Panzini I; Borini A; Coccia E; Setti PL; Palagiano A
Ann N Y Acad Sci; 2008 Apr; 1127():73-82. PubMed ID: 18443333
[TBL] [Abstract][Full Text] [Related]
10. [Chlamydia antibody testing for tubal factor subfertility].
Lardenoije CM; Land JA
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1981-5. PubMed ID: 17953171
[TBL] [Abstract][Full Text] [Related]
11. The value of Chlamydia trachomatis-specific IgG antibody testing and hysterosalpingography for predicting tubal pathology and occurrence of pregnancy.
Perquin DA; Beersma MF; de Craen AJ; Helmerhorst FM
Fertil Steril; 2007 Jul; 88(1):224-6. PubMed ID: 17296194
[TBL] [Abstract][Full Text] [Related]
12. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility.
den Hartog JE; Land JA; Stassen FR; Kessels AG; Bruggeman CA
Hum Reprod; 2005 Apr; 20(4):986-90. PubMed ID: 15640255
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based medicine for diagnostic questions.
Evers JL; Land JA; Mol BW
Semin Reprod Med; 2003 Feb; 21(1):9-15. PubMed ID: 12806555
[TBL] [Abstract][Full Text] [Related]
14. Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule based on medical history.
Coppus SF; Verhoeve HR; Opmeer BC; van der Steeg JW; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW
Hum Reprod; 2007 Oct; 22(10):2685-92. PubMed ID: 17675647
[TBL] [Abstract][Full Text] [Related]
15. [The most suitable tests for studying chlamydial infection in women with sterility].
Borisov I; Nalbanski B; Filipov E; Pŭnevska M; Kolarov G
Akush Ginekol (Sofiia); 1999; 38(4):23-5. PubMed ID: 10726347
[TBL] [Abstract][Full Text] [Related]
16. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage.
El Hakim EA; Gordon UD; Akande VA
Arch Gynecol Obstet; 2010 Apr; 281(4):727-33. PubMed ID: 19760187
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between CA-125 marker with the presence and severity of pelvic endometriosis].
Bianchi M; Macaya R; Durruty G; Manzur A
Rev Med Chil; 2003 Apr; 131(4):367-72. PubMed ID: 12870230
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum CA-125 and CA-72 in predicting endometriosis in infertility patients.
Molo MW; Kelly M; Radwanska E; Binor Z
J Reprod Med; 1994 Dec; 39(12):964-6. PubMed ID: 7884754
[TBL] [Abstract][Full Text] [Related]
19. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions.
Somigliana E; Viganò P; Tirelli AS; Felicetta I; Torresani E; Vignali M; Di Blasio AM
Hum Reprod; 2004 Aug; 19(8):1871-6. PubMed ID: 15218003
[TBL] [Abstract][Full Text] [Related]
20. [Anti-C. trachomatis IgG antibodies levels in serum to identify infertility caused by tubal damage].
Hernández-Trejo M; López-Hurtado M; Arteaga-Troncoso G; Guerra-Infante FM
Rev Invest Clin; 2009; 61(1):87-9. PubMed ID: 19507478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
